Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group (Q41753393)
Jump to navigation
Jump to search
scientific article published on July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group |
scientific article published on July 2000 |
Statements
1 reference
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group (English)
1 reference
1 reference
Katzenstein DA
1 reference
Hughes M
1 reference
Albrecht M
1 reference
Hammer S
1 reference
Para M
1 reference
Valdez H
1 reference
Haubrich R
1 reference
Liou S
1 reference
1 July 2000
1 reference
1 reference
16
1 reference
11
1 reference
1031-1037
1 reference
Identifiers
1 reference
1 reference